出生体重或胎龄调整的二线LCMSMS截断值改善新西兰新生儿CAH筛查
新西兰新生儿筛查先天性肾上腺皮质增生症(CAH)的阳性预测值约10%。结果显示,应用第97.5百分位二线调整截断值后,阳性预测值从10.8%升至80%,且不损失筛查敏感性。
要点
- 二线LCMSMS类固醇谱结合出生体重或胎龄调整截断值可显著降低CAH筛查假阳性率。
- 应用第97.5百分位调整截断值后,阳性预测值从10.8%升至80%。
- 调整截断值未损失筛查敏感性,推荐用于改善CAH新生儿筛查。
核心结论
- 使用出生体重或胎龄调整的二线筛查截断值可显著降低新西兰CAH新生儿筛查的假阳性率,且不损失筛查敏感性。
研究设计与样本
- 比较筛查阴性婴儿与确诊CAH病例的数据,采用方差分析确定出生体重和胎龄分组。
主要发现
- 一线免疫分析数据与胎龄的相关性优于出生体重,但二线类固醇测量与两者无差异。
- 为17-羟孕酮和一种类固醇比值测量建立了4个不同的出生体重和胎龄组。
- 应用第97.5百分位二线出生体重或胎龄调整截断值,研究期间产生10例阳性检测,其中8例真阳性、2例假阳性。
- 筛查阳性预测值从10.8%提高至80%。
关键数值与推荐
- 二线筛查截断值采用第97.5百分位,按出生体重或胎龄调整。
- 阳性预测值从10.8%提升至80%。
临床怎么用
- 在新生儿CAH筛查中,采用出生体重或胎龄调整的二线LCMSMS截断值可减少假阳性,提高阳性预测值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The positive predictive value of newborn screening for congenital adrenal hyperplasia (CAH) in New Zealand is approximately 10%. The use of a second tier liquid chromatography-tandem mass spectrometry bloodspot steroid profile test with birth weight- or gestational age-adjusted screening cutoffs may result in further screening improvements. METHODS: Three years of newborn screening data with additional second-tier steroid metabolites was evaluated (n = 167 672 births). Data from babies with a negative screening test and confirmed CAH cases were compared. First- and second-tier steroid measurements were correlated with both birth weight and gestational age. Analysis of variance was used to determine birth weight and gestational age groups. Screening cutoffs were determined and applied retrospectively to model screening performance. RESULTS: First-tier immunoassay data correlated better with gestational age than with birth weight, but there was no difference with second-tier steroid measurements. Four distinct birth weight and gestational age groups were established for 17-hydroxyprogesterone and a steroid ratio measurement. Application of 97.5th percentile second-tier birth weight- or gestational age-adjusted cutoffs would result in 10 positive tests over the period of the study with 8 true-positive screens and 2 false-positive tests. The positive predictive value of screening would be increased from 10.8% to 80%. CONCLUSIONS: The use of either birth weight- or gestational age-adjusted cutoffs for second-tier screening tests can significantly reduce the false positive rate of newborn screening for CAH in New Zealand without loss in screening sensitivity.
引用
- de Hora MR, Heather NL, Webster D, et al. Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand. J Clin Endocrinol Metab. 2021. PMID: 34058748. doi:10.1210/clinem/dgab383
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。